ARCHIVES

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

Professional Societies: AACR To Establish A Foundation To fund Outreach, Education

April 23, 1999

Grant Supplements, and Challenge Grants

February 20, 2009

R01 Payline To Increase From 21st to 22nd Percentile; Barcelona Hospital Wins BMS Cancer Research Grant

June 14, 2002

Conversation with The Cancer Letter: Is Republican Control Better Than Two-Party Stalemate?

December 19, 2014

House Still Sees Problems In NIH Financial Management

July 5, 1991

Limb-Sparing Surgery May Not Offer Better Quality of Life

August 28, 2009